APA (7th ed.) Citation

Omran, M., Blomqvist, L., Brandberg, Y., Pal, N., Kogner, P., Ståhlbom, A. K., . . . Bajalica-Lagercrantz, S. (2020). Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53. Hereditary Cancer in Clinical Practice, 18(1), 1. https://doi.org/10.1186/s13053-020-0133-5

Chicago Style (17th ed.) Citation

Omran, Meis, Lennart Blomqvist, Yvonne Brandberg, Niklas Pal, Per Kogner, Anne Kinhult Ståhlbom, Emma Tham, and Svetlana Bajalica-Lagercrantz. "Whole-body MRI Within a Surveillance Program for Carriers with Clinically Actionable Germline TP53 Variants - the Swedish Constitutional TP53 Study SWEP53." Hereditary Cancer in Clinical Practice 18, no. 1 (2020): 1. https://doi.org/10.1186/s13053-020-0133-5.

MLA (9th ed.) Citation

Omran, Meis, et al. "Whole-body MRI Within a Surveillance Program for Carriers with Clinically Actionable Germline TP53 Variants - the Swedish Constitutional TP53 Study SWEP53." Hereditary Cancer in Clinical Practice, vol. 18, no. 1, 2020, p. 1, https://doi.org/10.1186/s13053-020-0133-5.